Astra Industrial Group · TADAWUL:1212

Astra Industrial — Q3 2025 Earnings Presentation

24 slides from Astra Industrial's earnings presentation, 2025

  1. Slide 1: Investor Presentation Q3, 2025

    Investor Presentation Q3, 2025

  2. Slide 2: Contents

    2 Contents • Business Overview & Key Highlights 3 • Tabuk Pharmaceuticals 6 • Specialty Chemicals 10 • International Building Systems Factory 14 • Financial Performance Highlights 18 Corporate data Head Office: Riyadh, Saudi Arabia Organized: 2006 and listed 2008 Paid-in Capital: 800,000,000 SAR Tot

  3. Slide 3: Business Overview & Key Highlights

    Business Overview & Key Highlights

  4. Slide 4: Who we are

    4 Who we are Astra Industrial Group “the Group” is a Saudi industrial investment group headquartered in Riyadh with strong industrial footprint across KSA, Middle East, North Africa, India and Germany. The group is focused on creating long-term value to its shareholders by selecting appropriate indu

  5. Slide 5: Key Highlights

    5 Key Highlights Astra Industrial Group has affiliates in many countries and has set up partnerships to promote and distribute its products throughout Asia, Africa and Europe. As a key regional player, we have production facilities on three continents, sales and operations in more than 40 countries

  6. Slide 6: Tabuk Pharmaceuticals

    a GucluoJI pint “ee i I astra industries = oi — Tabuk Pharmaceuticals

  7. Slide 7: Tabuk Pharmaceuticals

    7 Tabuk Pharmaceuticals • With nearly 2,500 employees across the MENA region, • Tabuk Pharmaceuticals is a leading branded generic pharmaceutical company that is committed to improving the lives of patients. • Tabuk is leading the Pharmaceutical companies in Saudi private market with market share of

  8. Slide 8: Tabuk Pharmaceuticals

    8 Tabuk Pharmaceuticals Considered the second largest Pharmaceutical company in MENA & the 1st in KSA private sector, Tabuk Pharmaceuticals operates with advanced manufacturing facilities to produce a wide range of dosage forms and products; more than 300 registered products, via the most innovative

  9. Slide 9: Developments & Achievements

    9 Developments & Achievements in key therapeutic areas in KSA retail market1 Achievements Cardiovascular System (CVS): Tabuk ranks 1st with market share of 13%. Key Market Developments Respiratory: Tabuk Musculoskeletal: Tabuk ranks the 2nd with ranks the 1st with market KSA Anti-Infectives (AI): ma

  10. Slide 10: Specialty Chemicals

    a GucluoJI pint “ee i I astra industries = oi — Specialty Chemicals

  11. Slide 11: Specialty Chemicals

    11 Specialty Chemicals Revenue SAR 752 Mn Business share 33% Founded in 1988, Astrachem considered a leading company in the field of compounded fertilizers Total Assets and agrochemicals manufacturing capitalizing on deep experience, long heritage and broad dealer SAR 911 Mn network. Astrachem is sp

  12. Slide 12: Astra Chem

    12 Astra Chem Astrachem’s deep experience, long heritage and broad dealer Key Highlights 2025 network gives it market edge. Astrachem is a leading company in the • Expanding our network by adding new markets B2B with a field of compounded fertilizers and agrochemicals. The company cautious approach

  13. Slide 13: Astra Polymers

    13 Astra Polymers Key Highlights 2025 The petrochemical industry has faced a number of challenges, Since its inception 1993, Astra Polymers has continuously including the global economic slowdown, uncertainties arising from delivered exceptional value to customers in the thermoplastics new tariffs,

  14. Slide 14: International Building Systems Factory

    International Buildings Systems Factory

  15. Slide 15: International Building Systems Factory

    15 International Building Systems Factory International Building Systems Factory (IBSF) (Manufacturing and Contracting) started in 1993 and has grown to be one of the leading and reputed EPC organizations that was incorporated with a vision to meet the ever-growing demand within the commercial and i

  16. Slide 16: International Building Systems Factory Key Highlights 2025

    16 International Building Key Highlights 2025 Systems Factory Signed MoU with MCC/JSSL for the prestigious MBS Stadium project International Building Systems Factory (IBSF) is accredited with MOU’s have been signed with other steel fabricators such as Dadongwu ISO 9001, ISO 14001, ISO 45001, and AIS

  17. Slide 17: Our Satisfied Clients

    17 International Building Systems Factory Our Satisfied Clients:

  18. Slide 18: Financial Performance Highlights

    Financial Performance Highlights

  19. Slide 19: Performance Highlights

    19 Performance Highlights Strong Profitable YTD Growth combined with Healthy Operating cash flow This Quarter Year To Date SAR Mn 2024 2025 Variance 2024 2025 Variance P&L Items Revenue 689 730 +6% 2,341 2,279 -3% Gross Profit 324 346 +7% 1,012 1,045 +3% Income From Operations 164 182 11% 497 575 +1

  20. Slide 20: Growth Pillars

    20 Growth Pillars Tabuk pharma • Healthy organic growth in key markets such as KSA public Revenue Growth (SAR Mn) and KSA private markets. • Growth is driven by expansion of Saudi market, enhancement of commercial activities, continuing the growth momentum driven by organic volume growth and +6% -4%

  21. Slide 21: Profitability by Sector

    21 Profitability by Sector EBITDA Growth (SAR Mn) Tabuk pharma • Maintaining stable profitability growth and margin +9% -19% +121% -2% +11% expansion, consistently driven by our major markets. • This margin enhancement is driven by growth of sales 62 683 mainly in KSA private and public market. 34 S

  22. Slide 22: Consolidated Income Statement

    22 Consolidated Income Statement SAR Mn Sep-24 Sep-25 Gross Profit Continuing Operations • Steady growth in the consolidated GP % driven Revenue 2,341 2,279 mainly by Steel sector led, whilst Pharma and Cost of revenue (1,329) (1,234) Specialty chemical sector has shown flat Gross Profit 1,012 1,045

  23. Slide 23: Balance Sheet and Working Capital

    23 Balance Sheet and Liabilities 12/31/2024 9/30/2025 Working Capital Non-current liabilities Employees' defined benefit liabilities 157 168 12/31/2024 9/30/2025 Loans and lease liabilities 75 65 Assets Deferred tax liability 6 10 Non-current assets 238 243 Property, plant and equipment 818 850 Curr

  24. Slide 24: Thank You

    Thank You • Astra Industries Group • P.O.Box 1560 Riyadh 11441 KSA • Tel.: 00966 11 475 2002 Fax: 00966 11 475 2001 • info@aig.sa • www.aig.sa

Astra Industrial Group — Q3 2025 Earnings Presentation on 6ix